Submit Deal

CELLECTIS

Summary

Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 202 M

Avg. Deal Size£ 202 M

Market Context

Senior Management

Sort

jones day

HQ - Cleveland

legal advisors (1)

1 Shared Deal

1 For

£ 202 M

Total Value

freshfields bruckhaus deringer

HQ - London

legal advisors (1)

1 Shared Deal

1 Opposite

£ 202 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy